The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic Denervation
Abstract
Cerebral cortex samples from patients with Alzheimer's disease and from rats after experimental cholinergic denervation of the cerebral cortex exhibited reductions in the presynaptic marker choline acetyltransferase activity and in the number of M2 muscarine receptors, with no change in the number of M1 receptors. These results are in keeping with evidence that M2 receptors function in cholinergic nerve terminals to regulate the release of acetylcholine, whereas M1 receptors are located on postsynaptic cells and facilitate cellular excitation. New M1-selective agonists and M2-selective antagonists directed at post- or presynaptic sites deserve consideration as potential agents for the treatment of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6)
Mesulam, M.-M., Mufson, E. J., Wainer, B. H., & Levey, A. I. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90108-2 · Cited by 2,328
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Fonnum, F. (1969) · Biochemical Journal · doi:10.1042/bj1150465 · Cited by 1,035
The organization and some projections of cholinergic neurons of the mammalian forebrain
Fibiger, H. C. (1982) · Brain Research Reviews · doi:10.1016/0165-0173(82)90011-x · Cited by 818
Neurotransmitter-related enzymes in senile dementia of the alzheimer type
Davies, P. (1979) · Brain Research · doi:10.1016/0006-8993(79)90336-6 · Cited by 634
The distribution of septal projections to the hippocampus of the rat
Mosko, S., Lynch, G., & Cotman, C. W. (1973) · Journal of Comparative Neurology · doi:10.1002/cne.901520204 · Cited by 370
Pre- and postsynaptic neurochemical alterations in Alzheimer's disease
Reisine, T. D., Yamamura, H. I., Bird, E. D., Spokes, E., & Enna, S. J. (1978) · Brain Research · doi:10.1016/0006-8993(78)90562-0 · Cited by 342
Raiteri, M., Leardi, R., & Marchi, M. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21528-2 · Cited by 314
Davies, P., & Verth, A. H. (1977) · Brain Research · doi:10.1016/0006-8993(77)90758-2 · Cited by 313
Cited by
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918
Levey, A., Kitt, C., Simonds, W., Price, D., & Brann, M. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-10-03218.1991 · Cited by 918
Katzman, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141506 · Cited by 801
Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 692
Cholinergic function and intellectual decline in Alzheimer's disease
Collerton, D. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90002-3 · Cited by 601
Neurotransmitters in the regulation of neuronal cytoarchitecture
Mattson, M. P. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90020-3 · Cited by 520
Nicotinic acetylcholine binding sites in Alzheimer's disease
Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L., & Kellar, K. J. (1986) · Brain Research · doi:10.1016/0006-8993(86)90819-x · Cited by 486
Voytko, M., Olton, D., Richardson, R., Gorman, L., Tobin, Jr., & Price, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00167.1994 · Cited by 483
Jones, G. M. M., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A. (1992) · Psychopharmacology · doi:10.1007/bf02247426 · Cited by 476
The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467
Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations
Boer, C. G., Hatzikotoulas, K., Southam, L., Stefánsdóttir, L., Zhang, Y., Coutinho de Almeida, R., Wu, T. T., Zheng, J., Hartley, A., Teder-Laving, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.038 · Cited by 434
Muscarinic acetylcholine receptors as CNS drug targets
Langmead, C. J., Watson, J., & Reavill, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.009 · Cited by 419
The cholinergic system in Alzheimer's disease
Kása, P., Rakonczay, Z., & Gulya, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00028-2 · Cited by 409
A genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies
Jing, M., Zhang, P., Wang, G., Feng, J., Mesik, L., Zeng, J., Jiang, H., Wang, S., Looby, J. C., Guagliardo, N. A., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4184 · Cited by 387
Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease
Mesulam, M. ‐. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23415 · Cited by 375
Scopolamine model of dementia: electroencephalogram findings and cognitive performance
Ebert, & Kirch (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00393.x · Cited by 362
Levey, A. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13541 · Cited by 359
Animal models of Alzheimer's disease: experimental cholinergic denervation
Smith, G. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90016-1 · Cited by 337
Glutamate dysfunction in Alzheimer's disease: an hypothesis
Maragos, W. F., Greenamyre, J. T., Penney, J. B., & Young, A. B. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90025-7 · Cited by 334
Araujo, D. M., Lapchak, P. A., Robitaille, Y., Gauthier, S., & Quirion, R. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02497.x · Cited by 332
Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S., & Quirion, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09752.x · Cited by 320
Zhang, W., Basile, A. S., Gomeza, J., Volpicelli, L. A., Levey, A. I., & Wess, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01709.2002 · Cited by 315
Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain
Mash, D. C., & Potter, L. T. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90280-0 · Cited by 315
Self-citationSources of cortical rhythms in adults during physiological aging: A multicentric EEG study
Babiloni, C., Binetti, G., Cassarino, A., Dal Forno, G., Del Percio, C., Ferreri, F., Ferri, R., Frisoni, G., Galderisi, S., Hirata, K., et al. (2006) · Human Brain Mapping · doi:10.1002/hbm.20175 · Cited by 314
Intravenous nicotine in Alzheimer's disease: a pilot study
Newhouse, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A., & Murphy, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00174504 · Cited by 308
Sunderland, T. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800170032006 · Cited by 298
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., & DeKosky, S. T. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00068-1 · Cited by 295
Flynn, D. D., & Mash, D. C. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13113.x · Cited by 285
Self-citationBabiloni, C., Binetti, G., Cassetta, E., Forno, G. D., Percio, C. D., Ferreri, F., Ferri, R., Frisoni, G., Hirata, K., Lanuzza, B., et al. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.09.019 · Cited by 285
The Cholinergic Hypothesis of Neuropsychiatric Symptoms in Alzheimer's Disease
Cummings, J. L., & Back, C. (1998) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199821001-00009 · Cited by 274
Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia
Nordberg, A., Alafuzoff, I., & Winblad, B. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310115 · Cited by 270
Van der Zee, E. A., & Luiten, P. G. M. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00092-6 · Cited by 259
Mrzljak, L., Levey, A. I., & Goldman-Rakic, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5194 · Cited by 256
De Souza, E. B., Whitehouse, P. J., Kuhar, M. J., Price, D. L., & Vale, W. W. (1986) · Nature · doi:10.1038/319593a0 · Cited by 255
Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
Molchan, S. E., Martinez, R. A., Hill, J. L., Weingartner, H. J., Thompson, K., Vitiello, B., & Sunderland, T. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90017-g · Cited by 187
BABILONI, C., FRISONI, G., PIEVANI, M., VECCHIO, F., LIZIO, R., BUTTIGLIONE, M., GEROLDI, C., FRACASSI, C., EUSEBI, F., & FERRI, R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.08.005 · Cited by 171
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance
Geula, C., Dunlop, S. R., Ayala, I., Kawles, A. S., Flanagan, M. E., Gefen, T., & Mesulam, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15471 · Cited by 102
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed
Flicker, C., Serby, M., & Ferris, S. H. (1990) · Psychopharmacology · doi:10.1007/bf02244414 · Cited by 95
Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice
Krzywkowski, P., Ghribi, O., Gagné, J., Chabot, C., Kar, S., Rochford, J., Massicotte, G., & Poirier, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00061-5 · Cited by 74
Reinikainen, K. J., Riekkinen, P. J., Jolkkonen, J., Kosma, V.-M., & Soininen, H. (1987) · Brain Research · doi:10.1016/0006-8993(87)91052-3 · Cited by 54
De Keyser, J., Ebinger, G., & Vauquelin, G. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530070055011 · Cited by 49
Current Advances in Allosteric Modulation of Muscarinic Receptors
Jakubik, J., & El-Fakahany, E. E. (2020) · Biomolecules · doi:10.3390/biom10020325 · Cited by 48
Lai, M. K. P., Tsang, S. W. Y., Garcia-Alloza, M., Minger, S. L., Nicoll, J. A. R., Esiri, M. M., Wong, P. T.-H., Chen, C. P. L.-H., Ramírez, M. J., & Francis, P. T. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.016 · Cited by 29
Metadata
- Authors
- Mash, D. C., Flynn, D. D., & Potter, L. T.
- Venue
- Science
- Published
- 1985-05-31
- Volume
- 228
- Issue
- 4703
- Pages
- 1115-1117
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2080781505
- Cited by
- 698
- References
- 20
- FWCI
- 45.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.